The anti-inflammatory drug ibuprofen might partially protect
against Alzheimer’s disease, a new study finds. But researchers caution that
the findings, gleaned from the medical records of U.S. veterans, need to be confirmed
in a clinical trial pitting ibuprofen against other drugs or a placebo.
Researchers tapped into a huge database of veterans’ health
records to determine whether taking nonsteroidal anti-inflammatory drugs,
referred to as NSAIDs, affects the incidence of Alzheimer’s disease.
Log in
Subscribers, enter your e-mail address for full access to the Science News archives and digital editions.